08:45 AM EST, 12/30/2024 (MT Newswires) -- Inogen (INGN) said Monday it has received the US Food and Drug Administration's clearance for its SIMEOX 200 airway clearance device, which is designed to assist patients with chronic respiratory diseases in managing bronchial drainage.

A limited US launch is planned for next year, the company said.

Shares of Inogen jumped more than 10% in recent premarket activity.

Price: 9.49, Change: +0.91, Percent Change: +10.61